Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications

Annals of Internal Medicine

Volumn 129, Issue 3, 1998, Pages 229-240

  Chrousos, George P ^a   Torpy, David J ^b   Gold, Philip W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CIRCADIAN RHYTHM; CONFERENCE PAPER; FEMALE GENITAL SYSTEM; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPERPHAGIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EXPECTANCY; MELANCHOLIA; NEGATIVE FEEDBACK; NORADRENALIN RELEASE; PREGNANCY; PRIORITY JOURNAL;

EID: 0032145933     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-3-199808010-00012     Document Type: Conference Paper

References (90)

1. Adams F, tr. The Genuine Works of Hippocrates. Baltimore: Williams & Wilkins; 1939:19-41.
2. Temkin O, tr. Soranus' Gynecology. Book III. I. On the Retention of the Menstrual Flux and on Difficult and Painful Menstruation. Baltimore: Johns Hopkins Univ Pr; 1959:132-43.
3. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-52.
4. Ferin M. The menstrual cycle: an integrate view. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. v. 1. Philadelphia: Lippincott-Raven; 1996:103-21.
5. Drew FL. The epidemiology of secondary amenorrhea. J Chronic Dis. 1961; 14:396-407.
6. Berga S. Functional hypothalannic chronic anovulation. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. v. 1. Philadelphia: Lippincott-Raven; 1996:1061-75.
7. Fourestie V, de Lignieres B, Roudot-Thoraval F, Fulli-Lemaire I, Cremniter D, Nahoul K, et al. Suicide attempts in hypo-oestrogenic phases of the menstrual cycle. Lancet. 1986;2:1357-60.
8. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med. 1996;156:1837-40.
9. Taylor JW. The timing of menstruation-related symptoms assessed by a daily symptom rating scale. Acta Psychiatr Scand. 1974;60:87-105.
10. Collins A, Eneroth P, Landgren BM. Psychoneuroendocrine stress responses and mood as related to the menstrual cycle. Psychosom Med. 1985; 47:512-27.
11. Rivest S, Rivier C. The role of corticotropin-releasing factor and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev. 1995;16:177-99.
12. Shivers BD, Harlan RE, Morrell JI, Pfaff DW. Absence of estradiol concentration in cell nuclei of LHRH-immunoreactive neurones. Nature. 1983; 304:345-7.
13. Chen MD, O'Byrne KT, Chiappini SE, Hotchkiss J, Knobil E. Hypoglycemie 'stress' and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey: role of the ovary. Neuroendocrinology. 1992;56:666-73.
14. Plant TM. Gonadal regulation of hypothalamic gonadotropin-releasing hormone release in primates. Endocr Rev. 1986;7:75-88.
15. Sakakura N, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab. 1975;40:774-9.
16. Rabin DS, Johnson EO, Brandon DD, Liapi C, Chrousos GP. Glucocorticoids inhibit estradiol-mediated uterine growth: possible role of the uterine estradiol receptor. Biol Reprod. 1990;42:74-80.
17. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17:221-44.
18. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Monshima T, et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem. 1994;269:16433-42.
19. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev. 1994;15:409-20.
20. Lindholm J, Schultz-Moller N. Plasma and urinary cortisol in pregnancy and during estrogen-gestagen treatment. Scand J Clin Lab Invest. 1973;31:119-
21. Gallucci WT, Baum A, Laue L, Rabin DS, Chrousos GP, Gold PW, et al. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol. 1993;12:420-5.
22. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, et al. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychological stress in healthy young men. J Clin Endocrinol Metab. 1996;81:39-43.
23. Zukowska-Grojec Z, Shen GH, Capraro PA, Vaz CA. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Physiol Behav. 1991;49:771-7.
24. Spies HG, Pay KY, Yang SP. Coital and estrogen signals: a contrast in the preovulatory neuroendocrine networks of rabbits and rhesus monkeys. Biol Reprod. 1997;56:310-9.
25. Vamvakopoulos NC, Chrousos GP. Structural organization of the 5′ flanking region of the human corticotropin releasing hormone gene. DNA Seq. 1993;4:197-206.
26. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J Clin Invest. 1993;92:1896-902.
27. Kerdelhué B, Jones GS, Gordon K, Seltman H, Lenoir V, Melik Parsadaniantz S, et al. Activation of the hypothalamo-anterior pituitary corticotropin-releasing hormone, adrenocorticotropin hormone and β-endorphin systems during the estradiol 17 β-induced plasma LH surge in the ovariectomized monkey. J Neurosci Res 1995;42:228-35.
28. Peiffer A, Lapointe B, Barden N. Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology. 1991; 129:2166-74.
29. Paulmyer-Lacroix O, Héry M, Pugeat M, Grino M. The modulatory role of estrogens on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of ovariectomized rats: role of the adrenal gland J Neuroendocrinol. 1996;8:515-9.
30. Maeda K, Nagatani S, Estacio M, Tsukamura H. Novel estrogen feedback sites associated with stress-induced suppression of luteinizing hormone secretion in female rats. Cell Mol Neurobiol. 1996;16:311-24.
31. Saad MF, Damani S, Gingerich RL, Riad-Gabriei MG, Khan A, Boyadjian R, et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab. 1997;82:579-84.
32. Licinio J, Mantzoros C, Negrão AB, Cizza G, Wong ML, Bongiorno PB, et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med. 1997;3:575-9.
33. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-62.
34. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology. 1997;138:3859-63.
35. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes. 1997;46: 1235-8.
36. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS, Leptin accelerates the onset of puberty in normal female mice. J Clin Invest. 1997;99:391-5.
37. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab. 1997;82:2849-55.
38. Matkovic V, Ilich JZ, Badenhop NE, Skugor M, Clairmont A, Klisovic D, et al. Gain in body fat is inversely related to the nocturnal rise in serum leptin levels in young females. J Clin Endocrinol Metab. 1997;82:1368-72.
39. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-2.
40. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996;81:3419-23.
41. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81:3861-3.
42. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgert SG, Craft L, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530-2.
43. Liu JP, Clarke IJ, Funder JW, Engler D. Studies on the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa. J Clin Invest. 1994; 93:1439-50.
44. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol. 1991;260(2 pt 2):R328-34.
45. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med. 1997;3:238-40.
46. Hayward C, Killen JD, Wilson DM, Hammer LD, Litt IF, Kraemer HC, et al. Psychiatric risk associated with early puberty in adolescent girls. J Am Acad Child Adolesc Psychiatry. 1997;36:255-62.
47. Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR, et al. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J Clin Endocrinol Metab. 1990;71:1158-62.
48. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-62.
49. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 1991;254:421-3.
50. Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan CC, et al. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology. 1995;136:4650-8.
51. Webster EL, Lewis DB, Torpy DJ, Zachman KE, Rice KC, Chrousos GP. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology. 1996;137:5747-50.
52. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol. 1993;151:1587-96.
53. Scopa CD, Mastorakos G, Friedman TC, Melachrinou MC, Merino MJ, Chrousos GP. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol. 1994;145:1159-67.
54. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 1998;139:403-13.
55. Mastorakos G, Webster EL, Friedman TC, Chrousos GP. Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J Clin Invest. 1993;92:961-8.
56. Mastorakos G, Scopa CD, Vryonidou A, Friedman TC, Kattis D, Phenekos C, et al. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J Clin Endocrinol Metab. 1994;79: 934-9.
57. Calogero AE, Burrello N, Negri-Cesi P, Papale L, Palumbo MA, Cianci A, et al. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology. 1996;137:4161-6.
58. Ghizzoni L, Mastorakos G, Vottero A, Barreca A, Furlini M, Cesarone A, et al. Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. Endocrinology. 1997;138:4806-11.
59. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124-33.
60. Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, et al. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab. 1996;81:1046-50.
61. Makrigiannakis A, Margioris AN, Le Goascogne C, Zoumakis E, Nikas G, Stournaras C, et al. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 1995;57:1869-75.
62. Ferrari A, Petraglia F, Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J Steroid Biochem Mol Biol. 1995;54:251-5.
63. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos GP, Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology. 1996;64:85-92.
64. Nolten WE, Lindheimer MD, Rueckert PA, Oparil S, Ehrlich NE. Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab. 1980;51:466-72.
65. Challis JR, Matthews SG, Van Meir C, Ramirez MM. Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis. Placenta. 1995;16:481-502.
66. Linton EA, Perkins AV, Woods RJ, Eben F, Wolfe CD, Behan DP, et al. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels during the third trimester of normal human pregnancy. J Clin Endocrinol Metab. 1993;76:260-2.
67. Grino M, Chrousos GP, Margioris AN. The corticotropin releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun. 1987;148:1208-14.
68. Margioris AN, Grino M, Protos P, Gold PW, Chrousos GP. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. J Clin Endocrinol Metab. 1988;66:922-6.
69. Jones SA, Challis JR. Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem Biophys Res Commun. 1989;159:192-9.
70. Hillhouse EW, Grammatopoulos D, Milton NG, Quartero HW. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab. 1993; 76:736-41.
71. Quartero HW, Noort WA, Fry CH, Keirse MJ. Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins. 1991;42:137-50.
72. Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilation in the human fetal placental circulation. J Clin Endocrinol Metab. 1994;79:666-9.
73. Magiakou MA, Mastorakos G, Rabin D, Margioris AN, Dubbert B, Calogero AE, et al. The maternal hypothalamic-pituitary-adrenal axis in third trimester human pregnancy. Clin Endocrinol (Oxf). 1996;44:419-28.
74. Robinson BG, Emanuel RL, Frim DM, Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A. 1988;85:5244-8
75. Chrousos GP. Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity - a dynamic digital-to-analog modulation. Endocrinology. 1998;139:437-40.
76. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1:460-3.
77. Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab. 1996;81:1912-7.
78. Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman T, Kling M, et al. Psychopathology in patients with endogenous Cushing's syndrome: "atypical" or melancholic features. Clin Endocrinol (Oxf). 1995;43:433-42.
79. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab. 1997;82:912-9.
80. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347: 930-3.
81. Ballinger S. Stress as a factor in lowered estrogen levels in the early postmenopause. Ann N Y Acad Sci. 1990;592:95-113.
82. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med. 1988;319:413-20.
83. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians. 1996;108:374-81.
84. Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos GP, et al. Bone mineral density in women with depression. N Engl J Med. 1996; 335:1176-81.
85. Barefoot JC, Scholl MD. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. ACP J Club. 1993;93:1976-80.
86. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993;4:285-94.
87. Silverstone PH. Depression increases mortality and morbidity in acute life-threatening medical illness. J Psychosom Res. 1990;34:651-7.
88. Friedman TC, Mastorakos C, Newman TD, Mullen NM, Horton EG, Costello R, et al. Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J. 1996;43:645-55.
89. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest. 1991;87:831-7.
90. Michelson D, Galliven E, Hill L, Demitrack M, Chrousos GP, Gold P. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J Clin Endocrinol Metab. 1997;82: 2601-6.